New COO for US Pharma Research Firm

TargetRx, a US-based pharmaceutical marketing information services company, has appointed Teresa Winslow as Chief Operating Officer (COO).

For the last three years, Winslow has worked as an industry consultant for various healthcare, IT and pharmaceutical services companies. She previously spent 11 years at Dendrite International, which provides pharmaceutical customer relationship management solutions. Here, she held the positions of President of Dendrite Americas and Senior VP of Dendrite International, and served as Dendrite's executive advocate to Pfizer. She began her career at Eli Lilly, and has also worked in sales and marketing positions in the pharma divisions of Schering Plough Corporation and Key Pharmaceuticals (acquired by Schering Plough in 1986).

In her new role, Winslow will manage the company's sales, client services, marketing, operations, and technology teams. Michael Luby, President and CEO of TargetRx, praised her 'track record in balancing client service with company growth and profitability', and stated that 'adding a COO of Teresa's caliber to our executive team will further solidify TargetRx's position as an industry leader'.

The company is online at www.targetrx.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• TargetRx, Inc.
• All news